Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Go back to Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 14.34 --0 (-0%)
Previous Close $14.34    52 Week High $12.48 
Open $14.34    52 Week Low $1.60 
Day High $14.34    P/E N/A 
Day Low $14.34    EPS $-6.33 
Volume 2,211